Sigrid Machherndl-Spandl - Elisabethinen Hospital

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 119 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Successful Termination of a Multi-Year Wastewater-Associated Outbreak of NDM-5-carrying E. Coli in a Hemato-Oncological Center

Heidrun Kerschner, Linda Jernej,Adriana Cabal, Patrick Hyden,Sigrid Machherndl-Spandl, Lucia Berning, Anna Blaimschein,Werner Ruppitsch,Petra Apfalter,Rainer Hartl

Antimicrobial Resistance & Infection Control（2025）

Cited0Views0WOSBibtex

Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia

Christina Groiss, Stefanie Kreissl,Irene Strassl, Olga Saini, Dagmar Wipplinger, Robert Milanov, Emine Kaynak, Petra Hasengruber, Christoph Aichinger, Stefanie Nocker, Thomas Bauer,Veronika Buxhofer-Ausch,Sigrid Machherndl-Spandl, Michaela Binder,Alexander Nikoloudis,Michael Girschikofsky,Andreas Petzer,Ansgar Weltermann, Johannes Clausen

Journal of clinical medicine（2025）

Cited0Views0WOSBibtex

Impact of Early Cyclosporine A Levels on Acute Graft-Versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplantation Using in Vivo T-cell Depletion

Alexander Nikoloudis,Veronika Buxhofer-Ausch,Christoph Aichinger,Michaela Binder,Petra Hasengruber,Emine Kaynak,Dagmar Wipplinger,Robert Milanov,Irene Strassl,Olga Stiefel,Sigrid Machherndl-Spandl,Andreas Petzer,Ansgar Weltermann,Johannes Clausen

CYTOTHERAPYno. 5 (2024): 490-497

Cited1Views0WOSBibtex

Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center Analysis

Sigrid Machherndl-Spandl, Sarah Hannouf,Alexander Nikoloudis,Otto Zach,Irene Strassl,Emine Kaynak,Gerald Webersinke, Christine Gruber-Rossipal,Holger Rumpold,Wolfgang Schimetta,Johannes Clausen,Veronika Buxhofer-Ausch

CANCERS（2024）

Cited0Views0WOSBibtex

Therapy Management and Outcomes in Newly Diagnosed Unfit AML Patients Receiving Venetoclax Plus HMA - Insights from a Prospective Real-World Study in Switzerland and Austria

Thomas Pabst,Thomas Lehmann,Petra Pichler,Sigrid Machherndl-Spandl,Michael Gregor,Jeroen S. Goede,Sabine Gerull, Daniel Maria Mayer,Jean-Francois Lambert, Catherine Germanier,Georg Stuessi

BLOOD（2024）

Cited0Views0Bibtex

Donor C1 Group KIR-ligand Inferiority is Linked to Increased Mortality in Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide

Alexander Nikoloudis, Anna Bauhofer, Lena Griessl, Anke Habermehl, Christina Groiss,Michaela Binder,Robert Milanov, Thomas Bauer,Veronika Buxhofer-Ausch,Christoph Aichinger,Petra Hasengruber,Emine Kaynak,Dagmar Wipplinger,Irene Strassl,Olga Stiefel,Andreas Petzer,Holger Rumpold,Sigrid Machherndl-Spandl,Ansgar Weltermann,Johannes Clausen

Cytotherapy (2024)

Cited0Views0WOSBibtex

TOP-PIC: a New Tool to Optimize Pharmacotherapy and Reduce Polypharmacy in Patients with Incurable Cancer

Irene Strassl,Armin Windhager,Sigrid Machherndl-Spandl,Veronika Buxhofer-Ausch,Olga Stiefel,Ansgar Weltermann

Journal of Cancer Research and Clinical Oncologyno. 10 (2023): 7113-7123

Cited1Views0WOSBibtex

Bilaterale Orbitale Affektion Bei Multiplem Myelom

Baran Khalil,Laura Parzer,Sigrid Machherndl-Spandl,Sophie Haitchi-Petnehazy,Katharina Etmajer,Karl Haas,Peter Reinelt

Die Ophthalmologieno. 10 (2023): 1037-1041

Cited1Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn